mifepristone
Ligand Summary
A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.
UNII: 320T6RNW1F
PubChem: 55245
Guide to Pharmacology: 2805
ChEMBL: CHEMBL1276308
DrugCentral: 1805
LyCHI: WGH879VG45KF
Target Activities
154 Activities
Items per page:
10
1 – 10 of 154
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | ||||||
- | ||||||
EC50 | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||